Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database

• Κύριοι συγγραφείς: Liberata Sportiello (Συγγραφέας), Raffaella Di Napoli (Συγγραφέας), Nunzia Balzano (Συγγραφέας), Annamaria Mascolo (Συγγραφέας), Rosanna Ruggiero (Συγγραφέας), Luigi Di Costanzo (Συγγραφέας), Davida Monaco (Συγγραφέας), Giorgia Teresa Maniscalco (Συγγραφέας), Annalisa Capuano (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: MDPI AG, 2023-11-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

(1) Background: The purpose of study was to compare the safety profile of glatiramer with natalizumab, alemtuzumab and ocrelizumab in pregnant and lactating women affected by multiple sclerosis (MS). (2) Methods: Individual case safety reports (ICSRs) were retrieved from the European spontaneous rep...